Publication | Closed Access

Panobinostat, a histone deacetylase inhibitor, for latent-virus reactivation in HIV-infected patients on suppressive antiretroviral therapy: a phase 1/2, single group, clinical trial

Histone Deacetylase InhibitorTreatment And PreventionNeurovirologyMedicineImmunologyAntiviral TherapyPharmacotherapySingle GroupAntiviral DrugHivPharmacologyAids PathogenesisLatent-virus Reactivation